glp-1 tachycardia Modulation of Cardiac Ventricular Excitability by (Glucagon-Like Peptide-1) GLP-1 Receptor Agonists in Heart
Description
GLP-1R ,
Aims/hypothesis A protective role of sodiumglucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide 1 receptor agonists (GLP1-ra) in the development of diabetic retinopathy and diabetic macular oedema has been described in some recent studies, which may extend beyond glycaemic control
Side Effects: As a GLP-1 therapy, common side effects are typically gastrointestinal, including nausea, vomiting, and diarrhea.
Compare compounded tirzepatide, semaglutide, Zepbound, and Foundayo
